Skip to main content

Find Clinical Trials

Home
Conditions
Anlotinib

Clinical trial condition

Anlotinib

Explore clinical trials studying Anlotinib. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Anlotinib trial results

Completed

Anlotinib in Metastatic HER2 Negative Breast Cancer

NCT04002284

Conditions: Anlotinib, Antineoplastic Agents, Breast Diseases, +6 more
Locations: National Cacner Center/ Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

NCT05400070

Conditions: Anlotinib, Chemotherapy, Lung Cancer, +8 more
Locations: Tangdu Hospital, the Air Force Military University Xi'an, China

View Trial Details

Active, Not Recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions: Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations: Huai'an First People's Hospital Huai'an, China

Nanjing Drum Tower Hospital Nanjing, China

Zhongda Hospital Southeast University Nanjing, China

The First Affiliated Hospital of Soochow University Suzhou, China

View Trial Details